Molecular Imprinting for High-Added Value Metals: An Overview of Recent Environmental Applications

One of the most hot topics of recent research is the reuse of some compounds existing as pollutants in environment. These compounds (molecules, ions, complexes, etc.) are of high-added value and it will be ideal to selectively bind them with any environmental application and reuse them in their initial or modified form. The latter can be achieved using molecular imprinting. In the present review article, an overview of the recent attempts for the selective binding of some precious metals (i.e., gold, silver, and platinum) of high-added value is done using molecular imprinted polymers (MIPs) as materials. The simplicity of their use, their relatively low cost, and the broad range of possible guest molecules (small organic molecules, ions, metals, and also biological macromolecules) have since led to the important development of molecular imprinting

Removal of Arsenic (III) from water with a combination of Graphene Oxide (GO) and Granular Ferric Hydroxide (GFH) at the optimum molecular ratio

The occurrence of arsenic in water is a global problem for public health. Several removal technologies have been developed for arsenic removal from water, and adsorption onto iron oxyhydroxides is the most widely used technique. Granular ferric hydroxide (GFH) has been used mainly for As(V) removal, but it has the disadvantage that it can create a problem with the residual concentration of iron in the water. Moreover, graphene oxide (GO), which contains a large amount of reactive oxygen, exhibits high adsorbing capacity. In this study, the combined use of GO and GFH as adsorbent materials in different molar ratios was investigated in order to achieve the maximum As(III) removal from aqueous solutions. The effect of the adsorbent’s dosage, pH value, contact time, initial As(III), and different molar ratios of GO/GFH was examined. As depicted, the presence of GFH enhances the use of GO. In particular, the molar ratio of GO/GFH 2:1 (i.e., 0.2 g/L GO and 0.1 g/L GFH) is chosen as optimal at pH value 7.0 ± 0.1, while the removal percentage increased from 10% (absence of GFH) to 90% with the simultaneous addition of GFH. Freundlich isotherm and pseudo-second-order kinetic models described the experimental data adequately and the highest adsorption capacity that was achieved was 22.62 µg/g

Determining biokinetic coefficients for the upflow anaerobic sludge blanket reactor treating sugarcane wastewater in hot climate conditions

Acknowledgements The managing director of Imam Khomeini (pbuh) Agro-Industry in Shushtar and the laboratory expert of Agro-Industry Treatment Plant are highly appreciated for their cooperation in conducting this study.Peer reviewedPostprin

Evaluating the Quality of Research into a Single Prognostic Biomarker: A Systematic Review and Meta-analysis of 83 Studies of C-Reactive Protein in Stable Coronary Artery Disease

Background Systematic evaluations of the quality of research on a single prognostic biomarker are rare. We sought to evaluate the quality of prognostic research evidence for the association of C-reactive protein (CRP) with fatal and nonfatal events among patients with stable coronary disease. Methods and Findings We searched MEDLINE (1966 to 2009) and EMBASE (1980 to 2009) and selected prospective studies of patients with stable coronary disease, reporting a relative risk for the association of CRP with death and nonfatal cardiovascular events. We included 83 studies, reporting 61,684 patients and 6,485 outcome events. No study reported a prespecified statistical analysis protocol; only two studies reported the time elapsed (in months or years) between initial presentation of symptomatic coronary disease and inclusion in the study. Studies reported a median of seven items (of 17) from the REMARK reporting guidelines, with no evidence of change over time. The pooled relative risk for the top versus bottom third of CRP distribution was 1.97 (95% confidence interval [CI] 1.78–2.17), with substantial heterogeneity (I2 = 79.5). Only 13 studies adjusted for conventional risk factors (age, sex, smoking, obesity, diabetes, and low-density lipoprotein [LDL] cholesterol) and these had a relative risk of 1.65 (95% CI 1.39–1.96), I2 = 33.7. Studies reported ten different ways of comparing CRP values, with weaker relative risks for those based on continuous measures. Adjusting for publication bias (for which there was strong evidence, Egger's p<0.001) using a validated method reduced the relative risk to 1.19 (95% CI 1.13–1.25). Only two studies reported a measure of discrimination (c-statistic). In 20 studies the detection rate for subsequent events could be calculated and was 31% for a 10% false positive rate, and the calculated pooled c-statistic was 0.61 (0.57–0.66). Conclusion Multiple types of reporting bias, and publication bias, make the magnitude of any independent association between CRP and prognosis among patients with stable coronary disease sufficiently uncertain that no clinical practice recommendations can be made. Publication of prespecified statistical analytic protocols and prospective registration of studies, among other measures, might help improve the quality of prognostic biomarker research

Anti-inflammatory, antithrombotic and anti-oxidant bioactives of beer and brewery by-products, as ingredients of bio-functional foods, nutraceuticals, cosmetics, cosmeceuticals and pharmaceuticals with health promoting properties

Fermented alcoholic beverages and their by-products, including beer and breweries' bio-wastes like spent yeasts, grain, and hops, contain a plethora of natural bioactive compounds that have recently gained attention for their valorization as functional ingredients in several novel foods and nutraceuticals, as well as in drugs and cosmetics applications. Within this article, the natural bio-functional compounds of fermented beer product and breweries' by-products with anti-inflammatory, antithrombotic, and anti-oxidant bioactivities are thoroughly reviewed. The important roles of yeasts involved for such bioactives to be present in the fermented product and in the brewery bio-wastes are also outlined. The health promoting benefits of beer moderate consumption resulting from these bioactives, as part of a balanced diet, against inflammation-related chronic disorders is also discussed, along with the detrimental effects of beer consumption abuse and the potential benefits of alternative non-alcoholic beers. The mechanisms of action and synergism of the natural bioactives present in the fermented beer product and in breweries' by-products, with anti-inflammatory, anti-thrombotic, and antioxidant properties are also presented. Current research and future perspectives on valorizing bioactives of fermented beer and brewery by-products, such as spent yeasts, grain and hops in health-promoting functional foods, supplements, nutraceuticals cosmetics, cosmeceuticals, and pharmaceuticals are also thoroughly evaluated, while the limitations of their use are also discussed